-Conference call and webcast to be held at 8:30 a.m. EST-
TEL AVIV, Israel and MIAMI, Oct. 30, 2023 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of Carotid Artery Disease and stroke prevention, announced today it will report third quarter 2023 financial results on Monday, November 6th, 2023, before the financial markets open.
Management will host a conference call and webcast with the investment community at 8:30 am (EST) that same day to review financial results and provide an update on corporate developments.
Title: | InspireMD Third Quarter 2023 Financial Results and Corporate Update Conference Call and Webcast |
Date: | Monday, November 6th, 2023 |
Time: | 8:30 a.m. ET |
Conference Call Details: | Toll-Free: 1-877-407-4018 International: 1-201-689-8471 Conference ID: 13741842 |
business Update on Monday, November 6th>Full story available on Benzinga.com